1. Kissinger P. Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues. BMC Infect Dis 2015; 15(1): 307.

2. Bolbol-Haghigh N, Ebrahimi H, Norouzi P, Delvarianzadeh M. Evaluation and comparison of clinical and paraclinical diagnosis of Trichomonas vaginitis in women refered to Shahroud City Health Care Centers. J Shahrod Uni Med Sci Health Ser 2008; 3(1):33-38. [in Persian]

3. World Health Organization. 1995. Global prevalence and incidence of selected curable sexually transmitted diseases: overview and estimates. WHO, Geneva, Switzerland.

4. Jamali R, Zareikar B , Usofi S, Ghazghanchi A. Comparison of the sensitivity of wet smear and culture for diagnosis of Trichomonas vaginalis. J Lorestan Univ Med Sci 2006; 8: 80-5. [in Persian]

5. Hezarjaribi HZ, Fakhar M, Shokri A, Teshnizi SH, Sadough A, Taghavi M. Trichomonas vaginalis infection among Iranian general population of women: a systematic review and meta-analysis. Parasitol Res 2015; 114(4): 1291-300.

6. Schwebke JR, Burgess D. Trichomoniasis. Clin Microbiol Rev 2004; 17(4): 794-803.

7. Xiao JC, Xie LF, Fang SL, et al. Symbiosis of Mycoplasma hominis in Trichomonas vaginalis may link metronidazole resistance in vitro. Parasitol Res 2006; 100(1): 123-30.

8. Sorvillo F, Smith L, Kerndt P, Ash L. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 2001; 7(6): 927-32.

9. Ali V, Nozaki T. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by “amitochondriate” protozoan parasites. Clin Microbiol Rev 2007; 20(1): 164-87.

10. Wright JM, Dunn LA, Kazimierczuk Z, Burgess AG, Krauer KG, Upcroft P, et al. Susceptibility in vitro of clinically metronidazole- resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2- fluoro-2'-deoxyadenosine. Parasitol Res 2010; 107(4): 847-53.

11. Aazami M, Valizadeh M, Ezatpur B. Effectiveness of Dex Properanolol Hydrochloride on Trichomonas vaginalis growth under In-vitro condition. Submedical J Shahid Beheshti Uni Med Sci 2004; 6: 319. [in Persian]

12. Upson T, Andrews S. The genus Lavandula. Royal Botanic Gardens, Kew. 2004.

13. Moon T, Wilkinson JM, Cavanagh HM. Antiparasitic activity of two Lavandula essential oils against Giardia duodenalis, Trichomonas vaginalis and Hexamita inflata. Parasitol Res 2006; 99(6): 722-8.

14. Maria do Socorro SR, Mendonça-Filho RR, Bizzo HR, de Almeida Rodrigues I, Soares RM, Souto-Padrón T, Alviano CS, Lopes AH. Antileishmanial activity of a linalool-rich essential oil from Croton cajucara. Antimicrob Agents Chemother 2003; 47(6): 1895-901.

15. Machado M, Santoro G, Sousa M, Salgueiro L, Cavaleiro C. Activity of essential oils on the growth of Leishmania infantum promastigotes. Flavour Fragr J 2010; 25(3): 156-60.

16. Mir Majidi AS, Abbasi S. Optimization of ultrasonic emulsification conditions for the production of orange peel essential oil nanoemulsions. Monthly Nanotechnol 2015; 52(5): 2679–89.

17. Iravani S, Korbekandi H, Mirmohammadi SV, Zolfaghari B. Synthesis of silver nanoparticles: chemical, physical and biological methods. Res Pharm Sci 2014; 9(6): 385–406.

18. Elmi T, Gholami S, Fakhar M, Azizi F. A Review on the Use of Nanoparticles in the Treatment of Parasitic Infections. J Mazand Univ Med Sci 2013; 23(102): 127-34. [in Persian]

19. Hashtjin AM, Abbasi S. Nano-emulsification of orange peel essential oil using sonication and native gums. Food Hydrocoll 2015; 44: 40-8.

20. Adams RP. Identification of essential oil components by gas chromatography/mass spectroscopy. J Am Soc Mass Spectrom 1997; 6(8): 671-2.

21. Davies NW. Gas chromatographic retention indices of monoterpenesand sesquiterpenes on methyl silicone and carbowax 20M phases. J Chromato 1990; 503(42): 1-24.

22. Mahmoodi M, Nosratabadi J, Fekri A, Haghparast A, Sharifi I. Evaluation of meglumine antimonate therapy in cutaneous leishmaniasis: Comparison of in vitro sensitivity of Leishmania tropica isolates from patients treated with drug with clinical response . Koomesh 2003; 4(3): 39-46.

23. Ezatpur B, Badparva E, Ahmadi Sh, Rashidipur M, Ziaiye H. Investigation of Anti Trichomonas Vaginalis Activity of Lavandula angyustifolia Essential Oil in Invitro Media. Sci J Ilam Med Univ 2009; 16(4): 31-7. [in Persian]

24. Crouch ML, Alderete JF. Trichomonas vaginalis interactions with fibronectin and laminin. Microbiol 1999; 145(Pt 10): 2835-43.

25. Moon T, Wilkinson JM, Cavanagh HM. Antiparasitic activity of two Lavandula essential oils against Giardia duodenalis, Trichomonas vaginalis and Hexamita inflata. Parasitol Res 2006; 99(6): 722-8.

26. Bouzouita N, Kachouri F, Hamdi M, Chaabouni MM, Aissa RB, Zgoulli S, et al. Volatile constituents and antimicrobial activity of Lavandula stoechas L. oil from Tunisia. J Essential Oil Res 2005; 17(5): 584-6.